search
Back to results

Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery. (Prehab_2)

Primary Purpose

Colorectal Cancer

Status
Recruiting
Phase
Not Applicable
Locations
Hungary
Study Type
Interventional
Intervention
Trimodal rehabilitation + ERAS
ERAS + nutritional prehabilitation
Sponsored by
St. Borbala Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Colorectal Cancer focused on measuring ERAS, prehabilitation, fecal microbata

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • patient with histologically proven primary colorectal adenocarcinoma
  • any stage of colorectal cancer
  • elective operation
  • curative intention
  • informed consent signed by patient

Exclusion Criteria:

  • emergency operation
  • palliative operation
  • non-colorectal, second malignancy
  • pregnancy
  • patient not giving consent

Sites / Locations

  • Department of Surgery, St. Borbala HospitalRecruiting
  • St. Borbala HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Trimodal prehabilitation + ERAS

ERAS + nutritional prehabilitation

Arm Description

Patients receiving a formal preoperative preparation on: Physical status (walking, respiratory training) Nutrition (nutritional supplements) Mental status (weekly groups led by clinical psychologist on anxiety and depression management). Each patient will be treated in an ERAS program preoperatively.

Each patient will be treated in an ERAS program preoperatively. No specific preoperative training will be involved apart from nutritional status assessment and nutritional supplements.

Outcomes

Primary Outcome Measures

Length of hospital stay
Postoperative length of hospital stay in days.
Number of days spent on ICU (Intensive care unit).
Number of days observed on ICU right after operation.
Morbidity (early) classified after Clavien-Dindo.
7-day morbidity will be detailed assessed. Grade 3 or above morbidity rate will be assessed.
Morbidity (long term) classified after Clavien-Dindo.
30-day morbidity will be detailed assessed. Grade 3 or above morbidity rate will be assessed.
30-day mortality
30-day mortality of each patient will be recorded.
90-day mortality
90-day mortality of each patient will be recorded.
Change in preoperative functional status - 6MWD by operation
6MWD (6-minute walking distance test)
Change in postoperative functional status - 6MWD by the end of rehabilitation
6MWD (6-minute walking distance test)
Change in preoperative functional status - FVC by operation
Measured points: 4 weeks before surgery, on day of hospital admission
Change in preoperative functional status - FVC by the end of rehabilitation
Measured points: 4 weeks before surgery, 8 weeks after operation

Secondary Outcome Measures

Change of alpha- and beta-diversity of fecal microbata
Fecal microbara diversity will be measured at diagnosis, at the time of operation and 8 weeks after operation. We will assess diversity changes related to the intervention.

Full Information

First Posted
September 30, 2020
Last Updated
October 14, 2020
Sponsor
St. Borbala Hospital
Collaborators
Biological Research Centre, Szeged
search

1. Study Identification

Unique Protocol Identification Number
NCT04595604
Brief Title
Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery.
Acronym
Prehab_2
Official Title
Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery.
Study Type
Interventional

2. Study Status

Record Verification Date
October 2020
Overall Recruitment Status
Recruiting
Study Start Date
September 7, 2020 (Actual)
Primary Completion Date
September 7, 2025 (Anticipated)
Study Completion Date
September 7, 2030 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
St. Borbala Hospital
Collaborators
Biological Research Centre, Szeged

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Elective surgery is the most effective treatment option for colorectal cancer, however it has been recognized to be associated with high morbidity and mortality risks. ERAS (Enhanced Recovery After Surgery) is a preoperative multimodality treatment package, which has been well investigated and proved to be effective in reducing early postoperative morbidity, mortality, length of hospital stay and hospital costs, as well. Still, a good proportion of patients are not suitable for ERAS program, mainly based on lack of compliance and the impaired physical function before surgery. Trimodal Prehabilitation Program is a recently introduced preoperative preparation (training) program, which addresses improvement of physical, mental and nutritional status of the high risk elective surgery patients. This study aims to investigate the benefit of all efforts of a 4-6-week preoperative preparation program (Prehabilitation) being added to an established ERAS protocol. Additionally the effect of trimodal prehabilitation on gut microbiom diversity and its relation to clinical outcome will be analyzed.
Detailed Description
Aim: Colorectal cancer patients with a planned resection are tested if a complex, trimodal rehabilitation program can hold functional and morbidity benefit for them. In the prospective, randomized (2:1) study control patient group will be the well established and tested ERAS (enhanced recovery after surgery) Program. Study protocol in details: First visit: Outpatient Department of Surgery On both arms: History taking (including family history and oncologic history); Physical examination Operation indication, type of procedure and date of procedure agreed; Organizing further investigations, anesthesia; Operative risk assessment ("ACS - surgical risk calculator"); Study patient identifier Nr generated; Nurse-led ERAS/Prehab clinic: randomization On both arms: Randomization (Prehabilitation Program / ERAS Program). 2:1 Nurse led clinic assessment ("study nurse"): .i. CaseReportForm (CRF) filled in. .ii. Patient data (personal data, demographics, history) .iii. Anthropometrics (BMI, MUST, Body fat % measurement). .iv. Mental hygienic status assessment (smoking, alcohol consumption, anxiety, depression, sleeping disorders). .v. Cardiovascular status (resting HR, RR). .vi. Operative risk assessment (CR-Possum score). .vii. Preoperative counseling (operation type, preparation, pain management, discharge plan). .viii. Preoperative nutritional planning (education, nutrient prescription). .ix. Alcohol intake and smoking cessation - information given. .x. Stoma education started. . xi. Consent signed, patient workbook handed over. .xii. Respiratory test referral. xiii. Fecal sample collected and stored at -86 C. Physiotherapy, first visit Both on control and interventional arms: Respiratory function test recorded. Physical status tested (6MWD) on a treadmill. Just on Prehabilitation arm: Respiratory training education. Respiratory trainer device usage educated. Daily activity (walking) planned. Physiotherapy - second/third/fourth visit (weekly) Just on Prehabilitation arm: Previous week activity reviewed as to workbook. Physical assessment: 6MWD, FVC. Next week activity planned. Psychic preparation Just on Prehabilitation arm: • Once a week half an hour group relaxation training - regardless of the stage of prehabilitation program. Admission to the Surgical Ward a day before surgery Both on control and interventional arm: Preoperative assessment: .i. Anthropometrics (BMI, body fat%). .ii. Cardiovascular stage (resting HR and RR), ECG. .iii. Respiratory function tests. .iv. Physical status (6MWD) .v. Mental status (Hospital Anxiety and Depression Scale (HADS)) assessment. vi. Fecal sample collected and stored at -86 C. Preoperative preparation (as to ERAS protocol). Postoperative care (ITU, pain management, mobilization, oral nutrition built up, drains early removal, complications recorded (Clavien-Dindo-classification)). Stoma education. Dietary education. On discharge: Quality of Life (QoL) SF36 - (36-Item Short Form Survey from the RAND Medical Outcomes Study). Postoperative follow up: Both on control and interventional arms: • Assessment (8th week post op.): .i. Anthropometrics (BMI, Body fat %) .ii. Cardiovascular status (resting HR and RR). .iii. Respiratory function tests. .iv. Physical status (6MWD). .v. Fecal sample collected and stored at -86 C. - Long-term follow-up: 12, 24, 36, 48 and 60 months post operative assessment: Behavioral changes (alcohol abstinence, smoking cessation) Daily physical activity routine assessment. SF36 quality of life assessment Oncological outcome: local recurrence rate, distant recurrence rate, disease free survival, overall survival.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Colorectal Cancer
Keywords
ERAS, prehabilitation, fecal microbata

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Patients planned for elective, curative operations for colorectal cancer will be randomized into two groups: experimental group will take part in a dedicated 4-week multimodal preparation program followed by ERAS preoperative management, while control group will just participate in the ERAS program without specific physical and mental preparation. 2:1 randomization will be performed for interventional and control arm
Masking
InvestigatorOutcomes Assessor
Masking Description
Investigators and assessors will be blinded regarding preoperative preparation. Both randomization process and rehabilitation process will be carried out by a trained nurse, physiotherapist and psychotherapist, neither of them will be involved in outcome assessment.
Allocation
Randomized
Enrollment
500 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Trimodal prehabilitation + ERAS
Arm Type
Experimental
Arm Description
Patients receiving a formal preoperative preparation on: Physical status (walking, respiratory training) Nutrition (nutritional supplements) Mental status (weekly groups led by clinical psychologist on anxiety and depression management). Each patient will be treated in an ERAS program preoperatively.
Arm Title
ERAS + nutritional prehabilitation
Arm Type
Active Comparator
Arm Description
Each patient will be treated in an ERAS program preoperatively. No specific preoperative training will be involved apart from nutritional status assessment and nutritional supplements.
Intervention Type
Procedure
Intervention Name(s)
Trimodal rehabilitation + ERAS
Other Intervention Name(s)
Prehabilitation
Intervention Description
Prehabilitation will cover a range preoperative education and exercises (weekly) on diet, physical activity (daily walking), respiratory training (forced deep inspiration with spirometer device), as well as anxiolytic group psychotherapy.
Intervention Type
Procedure
Intervention Name(s)
ERAS + nutritional prehabilitation
Other Intervention Name(s)
Enhanced Recovery After Surgery
Intervention Description
Enhanced Recovery Program, including preoperative 4 weeks nutritional supplementation.
Primary Outcome Measure Information:
Title
Length of hospital stay
Description
Postoperative length of hospital stay in days.
Time Frame
45 days
Title
Number of days spent on ICU (Intensive care unit).
Description
Number of days observed on ICU right after operation.
Time Frame
45 days
Title
Morbidity (early) classified after Clavien-Dindo.
Description
7-day morbidity will be detailed assessed. Grade 3 or above morbidity rate will be assessed.
Time Frame
7 days (until 8th postoperative day) postoperative
Title
Morbidity (long term) classified after Clavien-Dindo.
Description
30-day morbidity will be detailed assessed. Grade 3 or above morbidity rate will be assessed.
Time Frame
30 days (until 31st postoperative day)
Title
30-day mortality
Description
30-day mortality of each patient will be recorded.
Time Frame
30 days (until 31st postoperative day)
Title
90-day mortality
Description
90-day mortality of each patient will be recorded.
Time Frame
90 days (until 91st postoperative day)
Title
Change in preoperative functional status - 6MWD by operation
Description
6MWD (6-minute walking distance test)
Time Frame
Measured points: 4 weeks before surgery, on day of hospital admission
Title
Change in postoperative functional status - 6MWD by the end of rehabilitation
Description
6MWD (6-minute walking distance test)
Time Frame
Measured points: 4 weeks before surgery, 8 weeks after operation
Title
Change in preoperative functional status - FVC by operation
Description
Measured points: 4 weeks before surgery, on day of hospital admission
Time Frame
Measured points: 4 weeks before surgery, on day of hospital admission
Title
Change in preoperative functional status - FVC by the end of rehabilitation
Description
Measured points: 4 weeks before surgery, 8 weeks after operation
Time Frame
Measured points: 4 weeks before surgery, 8 weeks after operation
Secondary Outcome Measure Information:
Title
Change of alpha- and beta-diversity of fecal microbata
Description
Fecal microbara diversity will be measured at diagnosis, at the time of operation and 8 weeks after operation. We will assess diversity changes related to the intervention.
Time Frame
Measured points: 4 weeks before surgery, on day of hospital admission and 8 weeks after surgery

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: patient with histologically proven primary colorectal adenocarcinoma any stage of colorectal cancer elective operation curative intention informed consent signed by patient Exclusion Criteria: emergency operation palliative operation non-colorectal, second malignancy pregnancy patient not giving consent
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Balazs Banky, Dr
Phone
+36208231642
Email
bankybalazs@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Andras Fulop, Dr
Phone
+36208258989
Email
fuli4321@gmail.com
Facility Information:
Facility Name
Department of Surgery, St. Borbala Hospital
City
Tatabánya
ZIP/Postal Code
2800
Country
Hungary
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Balazs Banky, PhD
Phone
+3620 8231642
Email
bankybalazs@gmail.com
First Name & Middle Initial & Last Name & Degree
Lóránd Lakatos, MD
Phone
+36305755326
Email
lakatoslorandl@gmail.com
First Name & Middle Initial & Last Name & Degree
András Fülöp, PhD
Facility Name
St. Borbala Hospital
City
Tatabánya
ZIP/Postal Code
2800
Country
Hungary
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Balazs Banky, PhD
Phone
+20 8231642
Email
bankybalazs@gmail.com
First Name & Middle Initial & Last Name & Degree
Krisztina Varga, MD
Email
dr.krisztina.varga@gmail.com

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Time Frame
10 years
Citations:
PubMed Identifier
35588252
Citation
Molenaar CJ, van Rooijen SJ, Fokkenrood HJ, Roumen RM, Janssen L, Slooter GD. Prehabilitation versus no prehabilitation to improve functional capacity, reduce postoperative complications and improve quality of life in colorectal cancer surgery. Cochrane Database Syst Rev. 2022 May 19;5(5):CD013259. doi: 10.1002/14651858.CD013259.pub2.
Results Reference
derived

Learn more about this trial

Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery.

We'll reach out to this number within 24 hrs